CEACAM5 and colorectal carcinoma: The AUROC of the four biomarkers was 0.771 for GAR, 0.698 for CEA, 0.676 for CA19‐9, and 0.635 for NLR, with GAR having the largest AUROC and demonstrating the closest relationship with outcome in patients with CRC.